Presumably, this selection of biomarkers may not be specific enough to operationalize NAFLD, as they also reflect other metabolic pathways to T2DM, including chronic inflammation (CRP) and dyslipidemia (blood lipids) [47], which may explain the unexpected results in this analysis. Here, CRP is linked to metabolic dysfunction-associated steatotic liver disease.